CHA Vaccine Institute Co., Ltd.   Report issue

For profit Phase 2
Founded: Seongnam Korea, Republic of (2000)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2012
NCT02692170
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

CHA Vaccine Institute Co., Ltd.

Active Ingredients

Drugs in Phase 2 Trials (3)

cvi-hbv-001 (1 trial)

cvi-hbv-002 (2 trials)

hepatitis b vaccine (recombinant) (recombivax) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis B (Phase 2)

Hepatitis B, Chronic (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 3